Organon & Co | Koszty Operacyjne



Operating Expenses Zmiana Data
Adcock Ingram Holdings ZAR 4.23B 196.72M 2024-12
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Celltrion KRW 718.99B 24.68B 2025-06
Cspc Pharmaceutical CNY 5.22B 248.9M 2025-03
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Divis Laboratories Ltd 17.93B 130M 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
Glaxosmithkline GBP 7.42B 408M 2024-12
Kangmei Pharma CNY 1.29B 13.37M 2025-03
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 311.35M 170.35M 2024-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 19.8M 9.46M 2024-12
Merck USD 9.44B 217M 2025-06
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Novartis USD 10.15B 579M 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Organon & Co USD 1.27B 144M 2025-06
Pharma Mar EUR 32.29M 9.66M 2025-06
Qiagen NV USD 397.57M 39.27M 2025-06
Sartorius EUR 722.5M 23.1M 2025-06
Sino Biopharmaceutical CNY 11.66B 352.34M 2024-12
Tilray USD 253.17M 16.55M 2024-11


Organon & Co Koszty Operacyjne - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.